Nathanael Lentz
Managing Partner @ Osage Venture Partners
Bala Cynwyd, United States
Nathanael Lentz is a Series A investor at Osage Venture Partners in Bala Cynwyd focused on Software and Enterprise Software. Nathanael V. Lentz is based out of Philadelphia, Pennsylvania and is the Managing Partner of Osage Venture Partners. Nathanael previously worked at DeepSurface Security as a Board Observer. Nathanael V. Lentz attended the Stanford University Graduate School of Business.
- Total investments:
- 56
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Nathanael Lentz invests in
Stages Nathanael Lentz invests in
Countries Nathanael Lentz invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 17 (30%)
- Enterprise Software 10 (18%)
- Artificial Intelligence 10 (18%)
- Machine Learning 7 (13%)
- Information Technology 7 (13%)
Stage
- Series A 16 (29%)
- Seed 9 (16%)
- Series B 9 (16%)
- Venture - Series Unknown 4 (7%)
- Series C 3 (5%)
Country
- United States 30 (54%)
- Israel 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Iridius is the compliance-by-design AI platform that enables regulated enterprises to design, build, and operate AI systems that are continuously compliant. In regulated industries, AI isn’t failing because of model capability — it’s failing because it can’t operate within real-world constraints: fragmented systems, complex workflows, and strictregulatory compliance requirements. Instead of treating compliance as a manual process that happens after systems are built, Iridius makes compliance part of how systems run. | $8.6M / Seed / Apr 23, 2026 | ||
| GlossAI bridges the gap between the content created by organisations and how people consume it .Today's audiences do not have the attention span to listen to anything for an extended period of time. Even those attending events, podcasts, training sessions, and zoom calls can't keep up. At GlossAI we get smart AI video generator that canturn any single piece of content into many short videos, blog posts and more various channels and use cases. | $14M / Series A / Feb 23, 2025 | ||
| Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for the end- to- end management of “clinical business operations”, which is the pharmaceutical industry vertical for planning, outsourcing and budgeting clinical trials. Biopharmaceutical companies outsource 90% of their clinical development pipelinespending billions of dollars engaging in highly complex outsourced relationships with thousands of global service providers, each using their own processes, systems and reporting structures. These sophisticated relationships require complex outsourcing strategies, demanding clinical financial planning, extensive sourcing due diligence and rigorous performance management. Currently the industry manages these activities in Excel, using labor intensive, inefficient processes, costing billions of dollars in infrastructure costs, regulatory non-compliance fines and delays to market. Clinical Maestro takes a radically different approach to the management of clinical portfolio through a transformative redesign of Excel-driven processes into end-to-end integrated workflows, breaking the communication and data integration siloes between pharma companies and their outsourcing partners. Clinical Maestro™ cases studies with leading pharmaceutical companies and CROs demonstrate savings of >80% vs. manual processes, >95% prediction accuracy for clinical study budgets and high user satisfaction and engagement. | $7M / Series A / Feb 06, 2024 | ||
| Arcanna.ai develops an AI-powered cybersecurity platform with the goal of increasing security operations efficiency by augmenting and scaling SOC analyst capacity. Arcanna.ai enables experts to train context-aware AI models that incorporate their cybersecurity and organizational distinctiveness knowledge and experience. For addressing today'sand tomorrow's attack volumes, Arcanna.ai employs an innovative and proprietary method for expert knowledge integration into a neural net that combines a continuous human feedback-loop, natural language processing, and deep learning. | $3.5M / Seed / Dec 19, 2023 | ||
| DeepHow develops an AI-powered learning platform for manufacturing, service, and repair. Wei-Liang Kao, Patrik Matos da Silva, and Samuel Zheng founded it in 2018, with its headquarters in New York City. | $14M / Series A / Dec 28, 2022 | ||
| Curavit is a “virtual CRO”, purpose-built to design and execute decentralized clinical trials. The company works with our clients to design their trials from first principles, based on the team’s decades of experience in research and digital health technologies. For each trial, they assign an experienced principal investigator, who is an expert inthe specific disease area, to develop the protocol and drive the regulatory submission process. Curavit manages participant recruitment, enrollment, and consent. Under the direction of the PI, their clinical study team executes the entire decentralized clinical trial. | $5M / Series A / Nov 14, 2022 | ||
| DeepSurface Security (www.deepsurface.com) is the first automated Predictive Vulnerability Management suite of tools that helps cybersecurity teams automate the process of analyzing and prioritizing vulnerabilities by risk contribution on enterprise networks. Created by a veteran cybersecurity team, DeepSurface Security is trusted by enterprisecompanies to identify, prioritize, and research vulnerabilities in their networks. Headquartered in Portland, Oregon, DeepSurface is a privately held company funded by Cascade Seed Fund, SeaChange Fund, and Voyager Capital. To learn more visit www.deepsurface.com. | $4.5M / Seed / Feb 08, 2022 | ||
| Malbek is an AI-fueled platform that provides enterprise contract lifecycle management that help organizations streamline contracting processes including request, redline review, approvals, signature, renewals, and and obligation tracking. The most modern and cutting-edge contract lifecycle management solution that is laser-focused on acceleratingcontract cycle time, improving efficiency, and increasing contract visibility. With a consumer-grade simplified user experience, it is a no-code and highly configurable solution for small, medium and large global businesses. | $15.3M / Series A / Sep 28, 2021 | ||
| DeepHow develops an AI-powered learning platform for manufacturing, service, and repair. Wei-Liang Kao, Patrik Matos da Silva, and Samuel Zheng founded it in 2018, with its headquarters in New York City. | $9M / Seed / Sep 15, 2021 | ||
| Mona provides intelligent and flexible AI monitoring for AI-first companies and teams who need to continuously adapt and optimize their production environments for fast business growth. Our platform enables machine learning teams to track data and model performance metrics in production, and get alerted on potential drifts. biases and integrityissues, to business risk and enable fast and reliable improvements. Customers across verticals use the platform for a variety of use cases such as fraud detection, data-driven healthcare, e-commerce marketing optimization, and revenue intelligence. Founded in late 2018 by product leaders and operators from Google and McKinsey & Co. | $7M / Seed / Aug 01, 2021 | ||
| See all 56 investments → | |||
Co-Investors
About Osage Venture Partners
Osage Venture Partners (OVP) invests in early stage, business-to-business (B2B) software companies headquartered on the East Coast from its offices just outside of Philadelphia, PA. With over $175M under management, OVP seeks to invest in determined and creative entrepreneurs and provide them with the assistance required to build high growth businesses.
Osage Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Claudia Dunnous
Chief Financial Officer
|
|||
Emily Foote
Principal
|
|||
James Quigley
Entrepreneur In Residence
|
|||
Jon Gulardo
Associate
|
|||
|
Nathanael Lentz
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Nathanael Lentz invest in?
Nathanael Lentz invests primarily in Software, Enterprise Software and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 56 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Nathanael Lentz?
Public channels for Nathanael Lentz include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Nathanael Lentz last invest?
The most recent investment recorded for Nathanael Lentz closed in Apr 2026. Shizune tracks 56 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
